News and Insights of 3D Printing and Manufacturing
Japanese video game developer Konami has teamed up with the prosthetic limb designer Open Bionic, to launch a 3D printed bionic arm inspired by the Metal Gear Solid (MGS) video game character Venom Snake.
Scientists from the Skolovo Institute of Science and Technology (Skoltech) have developed a novel method of 3D printing personalized ceramic bone implants.
Biotechnology firm United Therapeutics and Israeli bioprinting firm CollPlant have broadened their partnership to enter into the serial manufacturing of 3D printed kidneys.
Using 3D printers, researchers have collaborated from around the globe to develop nanoclay-based 3D bioprinted scaffolds which could be used to aid skeletal regeneration.
Canadian 3D bioprinting company Aspect Biosystems has launched a new grant program whereby the selected applicants will be supplied with the company’s proprietary RX1 bioprinters.
Researchers from the Delft University of Technology in the Netherlands have discovered 3D printed biodegradable magnesium scaffolds could have promising applications in the regeneration of critical-sized bone defects.
3D printing service provider PrintParts has partnered with automated post-processing developer PostProcess Technologies to rapidly-produce COVID-19 testing swabs in New York City (NYC).
A project led by academics at the University of Sheffield and the University of the Arts London (UAL) has received £766,675 of government funding to scale up its delivery of personal protective equipment (PPE) to refugees living in Jordan’s Zaatari camp.
Pharmaceutical 3D printing specialist FabRx has produced orodispersible 3D printed tablets, called Printlets, which are designed with Braille and Moon patterns on the surface to aid medicine taking for patients with visual impairment.
Global engineering technologies company, Renishaw, has concluded the extension component of its phase 1-2 clinical study, carried out jointly with pharmaceuticals expert Herantis Pharma, which investigated the safety and performance of its neuroinfuse drug delivery device and cerebral dopamine neurotrophic factor (CDNF), as a treatment for Parkinson’s disease.